Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 77 entries
Sorted by: Best Match Show Resources per page
Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.

Stem cells international

Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J.
PMID: 23577035
Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19.

Background. Regenerative therapy is an emerging treatment modality. To determine migration and retention of implanted cells, it is crucial to develop noninvasive tracking methods. The aim was to determine ex vivo magnetic resonance imaging (MRI) detection limits of ultrasmall...

Cite
Mathiasen AB, Hansen L, Friis T, et al. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105doi: 10.1155/2013/353105.
Mathiasen, A. B., Hansen, L., Friis, T., Thomsen, C., Bhakoo, K., & Kastrup, J. (2013). Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem cells international, 2013353105. https://doi.org/10.1155/2013/353105
Mathiasen, Anders Bruun, et al. "Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells." Stem cells international vol. 2013 (2013): 353105. doi: https://doi.org/10.1155/2013/353105
Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19. PMID: 23577035; PMCID: PMC3614076.
Copy Download .nbib Format: NLM
Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation.

Frontiers in neurology

Hanken K, Bosse M, Möhrke K, Eling P, Kastrup A, Antal A, Hildebrandt H.
PMID: 27708612
Front Neurol. 2016 Sep 21;7:154. doi: 10.3389/fneur.2016.00154. eCollection 2016.

BACKGROUND: Fatigue in multiple sclerosis (MS) patients appears to correlate with vigilance decrement as reflected in an increase in reaction time (RT) and errors with prolonged time-on-task.OBJECTIVES: The aim of this study was to investigate whether anodal transcranial direct...

Cite
Hanken K, Bosse M, Möhrke K, et al. Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation. Front Neurol. 2016;7:154doi: 10.3389/fneur.2016.00154.
Hanken, K., Bosse, M., Möhrke, K., Eling, P., Kastrup, A., Antal, A., & Hildebrandt, H. (2016). Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation. Frontiers in neurology, 7154. https://doi.org/10.3389/fneur.2016.00154
Hanken, Katrin, et al. "Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation." Frontiers in neurology vol. 7 (2016): 154. doi: https://doi.org/10.3389/fneur.2016.00154
Hanken K, Bosse M, Möhrke K, Eling P, Kastrup A, Antal A, Hildebrandt H. Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation. Front Neurol. 2016 Sep 21;7:154. doi: 10.3389/fneur.2016.00154. eCollection 2016. PMID: 27708612; PMCID: PMC5030283.
Copy Download .nbib Format: NLM
UV-Vis/FT-NIR .

Polymer chemistry

Kaastrup K, Aguirre-Soto A, Wang C, Bowman CN, Stansbury J, Sikes HD.
PMID: 26755925
Polym Chem. 2016;7(3):592-602. doi: 10.1039/C5PY01528F. Epub 2015 Nov 13.

In conjunction with a tertiary amine coinitiator, eosin, a photoreducible dye, has been shown to successfully circumvent oxygen inhibition in radical photopolymerization reactions. However, the role of O

Cite
Kaastrup K, Aguirre-Soto A, Wang C, et al. UV-Vis/FT-NIR . Polym Chem. 2015;7(3):592-602doi: 10.1039/C5PY01528F.
Kaastrup, K., Aguirre-Soto, A., Wang, C., Bowman, C. N., Stansbury, J., & Sikes, H. D. (2016). UV-Vis/FT-NIR . Polymer chemistry, 7(3), 592-602. https://doi.org/10.1039/C5PY01528F
Kaastrup, Kaja, et al. "UV-Vis/FT-NIR ." Polymer chemistry vol. 7,3 (2016): 592-602. doi: https://doi.org/10.1039/C5PY01528F
Kaastrup K, Aguirre-Soto A, Wang C, Bowman CN, Stansbury J, Sikes HD. UV-Vis/FT-NIR . Polym Chem. 2016;7(3):592-602. doi: 10.1039/C5PY01528F. Epub 2015 Nov 13. PMID: 26755925; PMCID: PMC4706378.
Copy Download .nbib Format: NLM
Achromatic light patterning and improved image reconstruction for parallelized RESOLFT nanoscopy.

Scientific reports

Chmyrov A, Leutenegger M, Grotjohann T, Schönle A, Keller-Findeisen J, Kastrup L, Jakobs S, Donnert G, Sahl SJ, Hell SW.
PMID: 28317930
Sci Rep. 2017 Mar 20;7:44619. doi: 10.1038/srep44619.

Fluorescence microscopy is rapidly turning into nanoscopy. Among the various nanoscopy methods, the STED/RESOLFT super-resolution family has recently been expanded to image even large fields of view within a few seconds. This advance relies on using light patterns featuring...

Cite
Chmyrov A, Leutenegger M, Grotjohann T, et al. Achromatic light patterning and improved image reconstruction for parallelized RESOLFT nanoscopy. Sci Rep. 2017;7:44619doi: 10.1038/srep44619.
Chmyrov, A., Leutenegger, M., Grotjohann, T., Schönle, A., Keller-Findeisen, J., Kastrup, L., Jakobs, S., Donnert, G., Sahl, S. J., & Hell, S. W. (2017). Achromatic light patterning and improved image reconstruction for parallelized RESOLFT nanoscopy. Scientific reports, 744619. https://doi.org/10.1038/srep44619
Chmyrov, Andriy, et al. "Achromatic light patterning and improved image reconstruction for parallelized RESOLFT nanoscopy." Scientific reports vol. 7 (2017): 44619. doi: https://doi.org/10.1038/srep44619
Chmyrov A, Leutenegger M, Grotjohann T, Schönle A, Keller-Findeisen J, Kastrup L, Jakobs S, Donnert G, Sahl SJ, Hell SW. Achromatic light patterning and improved image reconstruction for parallelized RESOLFT nanoscopy. Sci Rep. 2017 Mar 20;7:44619. doi: 10.1038/srep44619. PMID: 28317930; PMCID: PMC5357911.
Copy Download .nbib Format: NLM
Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies.

European journal of translational myology

Totzeck A, Mummel P, Kastrup O, Hagenacker T.
PMID: 28078065
Eur J Transl Myol. 2016 Sep 15;26(4):5962. doi: 10.4081/ejtm.2016.5962. eCollection 2016 Sep 15.

Neuromuscular junction disorders affect the pre- or postsynaptic nerve to muscle transmission due to autoimmune antibodies. Members of the group like myasthenia gravis and Lambert-Eaton syndrome have pathophysiologically distinct characteristics. However, in practice, distinction may be difficult. We present...

Cite
Totzeck A, Mummel P, Kastrup O, et al. Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies. Eur J Transl Myol. 2016;26(4):5962doi: 10.4081/ejtm.2016.5962.
Totzeck, A., Mummel, P., Kastrup, O., & Hagenacker, T. (2016). Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies. European journal of translational myology, 26(4), 5962. https://doi.org/10.4081/ejtm.2016.5962
Totzeck, Andreas, et al. "Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies." European journal of translational myology vol. 26,4 (2016): 5962. doi: https://doi.org/10.4081/ejtm.2016.5962
Totzeck A, Mummel P, Kastrup O, Hagenacker T. Clinical Features of Neuromuscular Disorders in Patients with N-Type Voltage-Gated Calcium Channel Antibodies. Eur J Transl Myol. 2016 Sep 15;26(4):5962. doi: 10.4081/ejtm.2016.5962. eCollection 2016 Sep 15. PMID: 28078065; PMCID: PMC5220212.
Copy Download .nbib Format: NLM
Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

Stem cells international

Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A.
PMID: 29056973
Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19.

BACKGROUND: Ischemic heart failure (IHF) has a poor prognosis in spite of optimal therapy. We have established a new allogeneic Cardiology Stem Cell Centre adipose-derived stromal cell (CSCC_ASC) product from healthy donors. It is produced without animal products, in...

Cite
Kastrup J, Schou M, Gustafsson I, et al. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370doi: 10.1155/2017/8506370.
Kastrup, J., Schou, M., Gustafsson, I., Nielsen, O. W., Møgelvang, R., Kofoed, K. F., Kragelund, C., Hove, J. D., Fabricius-Bjerre, A., Heitman, M., Haack-Sørensen, M., Lund, L. D., Johansen, E. M., Qayyum, A. A., Mathiasen, A. B., & Ekblond, A. (2017). Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem cells international, 20178506370. https://doi.org/10.1155/2017/8506370
Kastrup, Jens, et al. "Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study." Stem cells international vol. 2017 (2017): 8506370. doi: https://doi.org/10.1155/2017/8506370
Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19. PMID: 29056973; PMCID: PMC5625749.
Copy Download .nbib Format: NLM
Chemical synthesis on SU-8.

Chemical communications (Cambridge, England)

Qvortrup K, Taveras KM, Thastrup O, Nielsen TE.
PMID: 21063592
Chem Commun (Camb). 2011 Jan 28;47(4):1309-11. doi: 10.1039/c0cc03876h. Epub 2010 Nov 09.

In this paper we describe a highly effective surface modification of SU-8 microparticles, the attachment of appropriate linkers for solid-supported synthesis, and the successful chemical modification of these particles via controlled multi-step organic synthesis leading to molecules attached in...

Cite
Qvortrup K, Taveras KM, Thastrup O, et al. Chemical synthesis on SU-8. Chem Commun (Camb). 2010;47(4):1309-11doi: 10.1039/c0cc03876h.
Qvortrup, K., Taveras, K. M., Thastrup, O., & Nielsen, T. E. (2011). Chemical synthesis on SU-8. Chemical communications (Cambridge, England), 47(4), 1309-11. https://doi.org/10.1039/c0cc03876h
Qvortrup, Katrine, et al. "Chemical synthesis on SU-8." Chemical communications (Cambridge, England) vol. 47,4 (2011): 1309-11. doi: https://doi.org/10.1039/c0cc03876h
Qvortrup K, Taveras KM, Thastrup O, Nielsen TE. Chemical synthesis on SU-8. Chem Commun (Camb). 2011 Jan 28;47(4):1309-11. doi: 10.1039/c0cc03876h. Epub 2010 Nov 09. PMID: 21063592.
Copy Download .nbib Format: NLM
Current issues in Danish psychiatry.

Nordic journal of psychiatry

Fink-Jensen A, Kastrup M, Lolk A.
PMID: 19958259
Nord J Psychiatry. 2009 Nov;63(6):517-8. doi: 10.3109/08039480903444393.

No abstract available.

Cite
Fink-Jensen A, Kastrup M, Lolk A. Current issues in Danish psychiatry. Nord J Psychiatry. 2009;63(6):517-8doi: 10.3109/08039480903444393.
Fink-Jensen, A., Kastrup, M., & Lolk, A. (2009). Current issues in Danish psychiatry. Nordic journal of psychiatry, 63(6), 517-8. https://doi.org/10.3109/08039480903444393
Fink-Jensen, Anders, et al. "Current issues in Danish psychiatry." Nordic journal of psychiatry vol. 63,6 (2009): 517-8. doi: https://doi.org/10.3109/08039480903444393
Fink-Jensen A, Kastrup M, Lolk A. Current issues in Danish psychiatry. Nord J Psychiatry. 2009 Nov;63(6):517-8. doi: 10.3109/08039480903444393. PMID: 19958259.
Copy Download .nbib Format: NLM
WPA guidance on how to combat stigmatization of psychiatry and psychiatrists.

World psychiatry : official journal of the World Psychiatric Association (WPA)

Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Flórez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A.
PMID: 20975855
World Psychiatry. 2010 Oct;9(3):131-44. doi: 10.1002/j.2051-5545.2010.tb00296.x.

In 2009 the WPA President established a Task Force that was to examine available evidence about the stigmatization of psychiatry and psychiatrists and to make recommendations about action that national psychiatric societies and psychiatrists as professionals could do to...

Cite
Sartorius N, Gaebel W, Cleveland HR, et al. WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry. 2010;9(3):131-44doi: 10.1002/j.2051-5545.2010.tb00296.x.
Sartorius, N., Gaebel, W., Cleveland, H. R., Stuart, H., Akiyama, T., Arboleda-Flórez, J., Baumann, A. E., Gureje, O., Jorge, M. R., Kastrup, M., Suzuki, Y., & Tasman, A. (2010). WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World psychiatry : official journal of the World Psychiatric Association (WPA), 9(3), 131-44. https://doi.org/10.1002/j.2051-5545.2010.tb00296.x
Sartorius, Norman, et al. "WPA guidance on how to combat stigmatization of psychiatry and psychiatrists." World psychiatry : official journal of the World Psychiatric Association (WPA) vol. 9,3 (2010): 131-44. doi: https://doi.org/10.1002/j.2051-5545.2010.tb00296.x
Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Flórez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A. WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry. 2010 Oct;9(3):131-44. doi: 10.1002/j.2051-5545.2010.tb00296.x. PMID: 20975855; PMCID: PMC2948719.
Copy Download .nbib Format: NLM
Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation.

Interventional neurology

Kastrup A, Brunner F, Hildebrandt H, Roth C, Winterhalter M, Giessing C, Papanagiotou P.
PMID: 30410521
Interv Neurol. 2018 Oct;7(6):431-438. doi: 10.1159/000489708. Epub 2018 Jul 11.

BACKGROUND: In patients with large vessel occlusions, endovascular treatment (ET) has been shown to be superior to intravenous thrombolysis (IVT) in recent trials. However, it is currently unclear if patients with mild strokes also benefit from ET.METHODS: We compared...

Cite
Kastrup A, Brunner F, Hildebrandt H, et al. Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation. Interv Neurol. 2018;7(6):431-438doi: 10.1159/000489708.
Kastrup, A., Brunner, F., Hildebrandt, H., Roth, C., Winterhalter, M., Giessing, C., & Papanagiotou, P. (2018). Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation. Interventional neurology, 7(6), 431-438. https://doi.org/10.1159/000489708
Kastrup, Andreas, et al. "Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation." Interventional neurology vol. 7,6 (2018): 431-438. doi: https://doi.org/10.1159/000489708
Kastrup A, Brunner F, Hildebrandt H, Roth C, Winterhalter M, Giessing C, Papanagiotou P. Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation. Interv Neurol. 2018 Oct;7(6):431-438. doi: 10.1159/000489708. Epub 2018 Jul 11. PMID: 30410521; PMCID: PMC6216716.
Copy Download .nbib Format: NLM
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study.

Journal of clinical medicine

Nilsson E, Kastrup J, Sajadieh A, Boje Jensen G, Kjøller E, Kolmos HJ, Wuopio J, Nowak C, Larsson A, Jakobsen JC, Winkel P, Gluud C, Iversen KK, Ärnlöv J, Carlsson AC.
PMID: 31963719
J Clin Med. 2020 Jan 18;9(1). doi: 10.3390/jcm9010265.

Elevated pregnancy-associated plasma protein A (PAPP-A) is associated with mortality in acute coronary syndromes. Few studies have assessed PAPP-A in stable coronary artery disease (CAD) and results are conflicting. We assessed the 10-year prognostic relevance of PAPP-A levels in...

Cite
Nilsson E, Kastrup J, Sajadieh A, et al. Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study. J Clin Med. 2020;9(1)doi: 10.3390/jcm9010265.
Nilsson, E., Kastrup, J., Sajadieh, A., Boje Jensen, G., Kjøller, E., Kolmos, H. J., Wuopio, J., Nowak, C., Larsson, A., Jakobsen, J. C., Winkel, P., Gluud, C., Iversen, K. K., Ärnlöv, J., & Carlsson, A. C. (2020). Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study. Journal of clinical medicine, 9(1), . https://doi.org/10.3390/jcm9010265
Nilsson, Erik, et al. "Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study." Journal of clinical medicine vol. 9,1 (2020). doi: https://doi.org/10.3390/jcm9010265
Nilsson E, Kastrup J, Sajadieh A, Boje Jensen G, Kjøller E, Kolmos HJ, Wuopio J, Nowak C, Larsson A, Jakobsen JC, Winkel P, Gluud C, Iversen KK, Ärnlöv J, Carlsson AC. Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-Study. J Clin Med. 2020 Jan 18;9(1). doi: 10.3390/jcm9010265. PMID: 31963719; PMCID: PMC7019890.
Copy Download .nbib Format: NLM
Endovascular Therapy vs. Thrombolysis in Pre-stroke Dependent Patients With Large Vessel Occlusions Within the Anterior Circulation.

Frontiers in neurology

Kastrup A, Roth C, Politi M, Alexandrou M, Hildebrandt H, Schröter A, Papanagiotou P.
PMID: 34149598
Front Neurol. 2021 Jun 02;12:666596. doi: 10.3389/fneur.2021.666596. eCollection 2021.

No abstract available.

Cite
Kastrup A, Roth C, Politi M, et al. Endovascular Therapy vs. Thrombolysis in Pre-stroke Dependent Patients With Large Vessel Occlusions Within the Anterior Circulation. Front Neurol. 2021;12:666596doi: 10.3389/fneur.2021.666596.
Kastrup, A., Roth, C., Politi, M., Alexandrou, M., Hildebrandt, H., Schröter, A., & Papanagiotou, P. (2021). Endovascular Therapy vs. Thrombolysis in Pre-stroke Dependent Patients With Large Vessel Occlusions Within the Anterior Circulation. Frontiers in neurology, 12666596. https://doi.org/10.3389/fneur.2021.666596
Kastrup, Andreas, et al. "Endovascular Therapy vs. Thrombolysis in Pre-stroke Dependent Patients With Large Vessel Occlusions Within the Anterior Circulation." Frontiers in neurology vol. 12 (2021): 666596. doi: https://doi.org/10.3389/fneur.2021.666596
Kastrup A, Roth C, Politi M, Alexandrou M, Hildebrandt H, Schröter A, Papanagiotou P. Endovascular Therapy vs. Thrombolysis in Pre-stroke Dependent Patients With Large Vessel Occlusions Within the Anterior Circulation. Front Neurol. 2021 Jun 02;12:666596. doi: 10.3389/fneur.2021.666596. eCollection 2021. PMID: 34149598; PMCID: PMC8206778.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 77 entries